North America ACE Inhibitors Market Trends, Competition, Opportunities, 2019-2023 & 2024-2029 with Pfizer, Novartis, and AstraZeneca Leading the $2.93 Billion Industry
November 12, 2024 10:53 ET
|
Research and Markets
Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "North America ACE Inhibitors Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
Angiotensin Converting Enzyme (ACE) Inhibitors Strategic Research Report 2024-2030: Increasing Focus on Lifestyle Management and Preventive Care Sustains Demand f
October 30, 2024 11:48 ET
|
Research and Markets
Dublin, Oct. 30, 2024 (GLOBE NEWSWIRE) -- The "Angiotensin Converting Enzyme (ACE) Inhibitors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
Atrial Fibrillation Drug Pipeline Research Report 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive Landscape
October 14, 2024 10:37 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Atrial Fibrillation - Pipeline...
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
March 11, 2024 09:01 ET
|
Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Angina Pectoris Drugs Market by Type, by Drugs, by Route of Administration, by End-Users, and By Region" report has been added to ...
Hypertrophic Cardiomyopathy Therapeutics Market Predicted to Reach $1.48 Billion by 2028, Driven by Advances in Personalized Medicine and Genetic Testing - Long-term Forecasts to 2033
January 31, 2024 07:45 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Hypertrophic Cardiomyopathy (HCM) Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The...
Antihypertensive Drug Market to Expand with Promising CAGR of 4.7% through 2030: Regional Growth Opportunities for Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-Adrenergic Blockers
January 30, 2024 07:11 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Antihypertensive Drug Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global Ischemic Heart Disease (IHD) Drugs Market Set to Expand, Projected Value of $7.9 Billion by 2028
September 21, 2023 09:58 ET
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Ischemic Heart Disease Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Specialty Clinics Emerge as Key End-Users in the Global Angina Pectoris Drugs Market 2023-2030
September 20, 2023 06:23 ET
|
Research and Markets
Dublin, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The "Global Angina Pectoris Drugs Market by Type, Drugs, Route of Administration, End-Users - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
Global Antihypertensive Drugs Market Outlook 2023-2030 by Therapy, Type of Drug, and Region
July 26, 2023 05:08 ET
|
Research and Markets
Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The Global Antihypertensive Drugs Market Outlook 2023-2030 report has been added to ResearchAndMarkets.com's offering. The Global Antihypertensive Drugs...
Global Nephrology Drugs Market Projected to Garner a Revenue of $21,454.5 Million and Rise at a CAGR of 6.0% during the Forecast Period 2021-2028 [170-Pages] | Exclusive by Research Dive
February 06, 2023 09:01 ET
|
Research Dive
New York, USA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global nephrology drugs market is anticipated to generate a revenue of $21,454.5 million and...